Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2001

Lee MJ, Thangada S, Paik JH, Sapkota GP, Ancellin N, Chae SS, et al. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell. 2001;8(3):693-704.

Ely SA, Werner A, Chadburn A. An angiocentric orbital lesion with an immature natural killer cell immunophenotype. Hum Pathol. 2001;32(3):339-42.

Wang S, Saboorian MH, Frenkel EP, Haley BB, Siddiqui MT, Gokaslan S, et al. Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol. 2001;116(4):495-503.

Waltregny D, Leav I, Signoretti S, Soung P, Lin D, Merk F, et al. Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27. Mol Endocrinol. 2001;15(5):765-82.

Johnson RA, Ince TA, Scotto KW. Transcriptional repression by p53 through direct binding to a novel DNA element. J Biol Chem. 2001;276(29):27716-20.

Signoretti S, Loda M. Estrogen receptor beta in prostate cancer: brake pedal or accelerator? Am J Pathol. 2001;159(1):13-6.

Simmons WJ, Simms M, Chiarle R, Mackay F, Tsiagbe VK, Browning J, et al. Induction of germinal centers by MMTV encoded superantigen on B cells. Dev Immunol. 2001;8(3-4):201-11.

Siddiqui MT, Saboorian MH, Ashfaq R. Combined FNA/core needle biopsy. Breast J. 2001;7(3):202-3.

Chiarle R, Pagano M, Inghirami G. The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. Breast Cancer Res. 2001;3(2):91-4.

Chen X, Zhang Y, Douglas L, Zhou P. UV-damaged DNA-binding proteins are targets of CUL-4A-mediated ubiquitination and degradation. J Biol Chem. 2001;276(51):48175-82.